In PIK3R1-reduced renal cancer, activation of GSK3β/CTNNB1/Wnt pathway secondary to AKT signaling leads to cancer stem cell properties and enhanced expression of cadherins and EMT-related proteins14. Here, GSK3B is linked to cancer.